Immune checkpoint inhibitor therapy and elevated levels of C-reactive protein associated with COVID-19 aggravation in patients with lung cancer

BACKGROUND: COVID-19 has become a significant health threat and a primary healthcare concern among the most vulnerable patients with cancer. Patients with COVID-19 who have lung cancer are at great risk and need careful monitoring if they are affected. This study aimed to investigate the clinical ch...

Descripción completa

Detalles Bibliográficos
Autores principales: Maki, Masatoshi, Takada, Ryo, Taniguchi, Akihiko, Nomura, Naoyuki, Kuramoto, Seiichiro, Chiko, Yuki, Okada, Toshiaki, Saito, Seiji, Tamura, Koji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9624015/
https://www.ncbi.nlm.nih.gov/pubmed/36316726
http://dx.doi.org/10.1186/s40780-022-00259-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9624015/
https://www.ncbi.nlm.nih.gov/pubmed/36316726
http://dx.doi.org/10.1186/s40780-022-00259-6

Ejemplares similares